Internal Medicine · 2005 · 16 citations · 12 references
MedicineHematologyOncologyGastrointestinal OncologyMetastasisNeoplasiaGastrointestinal Stromal TumorsMesenchymal TumorsMetastatic Gastrointestinal CancerPulmonary TuberculosisDurable Clinical ResponseGastrointestinal TuberculosisMetastatic Gastrointestinal Stromal TumorsMetastatic Liver TumorsTuberculosis In Immunocompromised Hosts
We describe a patient who had a metastatic gastrointestinal stromal tumor (GIST) after previous failed extensive therapy, including multiple surgeries and hepatic artery embolization. Within a few months of starting administration of imatinib mesylate, the patient exhibited a clinical response with grade 3 neutropenia, when pulmonary tuberculosis developed. A c-kit mutation in exon 11 was detected only in metastatic liver specimens. It is unclear whether or not pulmonary tuberculosis may be induced by imatinib mesylate treatment, but caution is warranted in immunocompromised GIST patients. This is the first report of tuberculosis associated with neutropenia during imatinib mesylate treatment.
12
Gain-of-Function Mutations of c- <i>kit</i> in Human Gastrointestinal Stromal Tumors
Seiichi Hirota, Koji Isozaki, Y Moriyama et al. · Science · 1998 · 4.5K citations
Clinical management of gastrointestinal stromal tumors: Before and after STI-571
Ronald P. DeMatteo, Michael C. Heinrich, Wael El‐Rifai et al. · Human Pathology · 2002 · 637 citations